Presence of SARS-CoV-2 transcripts in the choroid plexus of MS and non-MS patients with COVID-19

Although primarily targeting the respiratory system, coronavirus disease 2019 (COVID-19) affects the CNS in up to 80% of patients.[1][1] Yet, findings on COVID-19 neuropathology have been conflicting: autopsy reports range from inflammatory CNS syndromes, cerebrovascular events,[1][1] and

Saved in:
Bibliographic Details
Main Authors: Fuchs, Vidmante (Author) , Kutza, Michael (Author) , Wischnewski, Sven (Author) , Deigendesch, Nikolaus (Author) , Lutz, Luc (Author) , Kulsvehagen, Laila (Author) , Ricken, Gerda (Author) , Kappos, Ludwig (Author) , Tzankov, Alexandar (Author) , Hametner, Simon (Author) , Frank, Stephan (Author) , Schirmer, Lucas (Author) , Pröbstel, Anne-Katrin (Author)
Format: Article (Journal)
Language:English
Published: March 2021
In: Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology
Year: 2021, Volume: 8, Issue: 2, Pages: 1-5
ISSN:2332-7812
DOI:10.1212/NXI.0000000000000957
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1212/NXI.0000000000000957
Verlag, lizenzpflichtig, Volltext: https://nn.neurology.org/content/8/2/e957
Get full text
Author Notes:Vidmante Fuchs, Michael Kutza, Sven Wischnewski, Nikolaus Deigendesch, Luc Lutz, Laila Kulsvehagen, Gerda Ricken, Ludwig Kappos, Alexandar Tzankov, Simon Hametner, Stephan Frank, Lucas Schirmer and Anne-Katrin Pröbstel
Description
Summary:Although primarily targeting the respiratory system, coronavirus disease 2019 (COVID-19) affects the CNS in up to 80% of patients.[1][1] Yet, findings on COVID-19 neuropathology have been conflicting: autopsy reports range from inflammatory CNS syndromes, cerebrovascular events,[1][1] and
Item Description:Gesehen am 18.08.2021
Physical Description:Online Resource
ISSN:2332-7812
DOI:10.1212/NXI.0000000000000957